All Products

OM 369
OM 369 Syrup
August 8, 2019
Linzodin Syrup
August 8, 2019
Show all

Linzodin Tabs

Clear Choice to treat infection caused by MRSA

Description

LINZOLIDE

CLEAR CHOICE TO TREAT INFECTIONS CAUSED BY MRSA

OFFERS A FAVORABLE SAFETY PROFILE IN A BROAD RANGE OF PATIENTS

 

Exhibits good activity against Staphylococci including strains resistant to Methicillin Glycopeptides & other antibacterial agents. Highly active against penicillin resistant S. Pneumonaei, Vancomycin-resistant E.Faecalis, Corynebacterium Sp, Moraxella Catarrhalis and Bacteroides Fragilis. Excellent option with significant resistant gram positive bacteremic infections. Safe and efficacious for Nosocomial Pneumonia.

INDICATIONS :

  • CAP
  • UTI
  • SSTI
  • BACTERAEMIA
  • DIABETIC FOOT INFECTIONS
  • BONE & BONE MARROW INFECTIONS

 

DOSAGE & ADMINISTRATION:

Adults : 1 Tab (400 mg / 600 mg) twice a day for 10-14 days.

Children <12 Years : 20 mg – 30 mg / kg body weight in 2 divided doses in a day for 10-14 days.

 

MRP Rs. 1600

 

 

Reviews (0)

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.